Skip to content

Clinical trials

Lung Diseases trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20173
20191
20222
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong2
AVEO Pharmaceuticals, Inc.1
AstraZeneca1
Bayer1
Eli Lilly and Company1
Hoffmann-La Roche1
Nuvalent Inc.1
Pfizer1
Queen Mary Hospital, Hong Kong1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases12
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms6
Carcinoma5
Respiratory Tract Diseases5
Neoplasms4
Neoplasms by Site4
Respiratory Tract Neoplasms4
Thoracic Neoplasms4
Bronchial Neoplasms3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.